1. A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection. Issue 1 (12th September 2022) Authors: Price, Angie S.; Nelson, Amy K.; Ghosh, Alip; Kottilil, Shyamasundaran; Chua, Joel V. Journal: Journal of medical virology Issue: Volume 95:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Are we nearing the end in the fight against hepatitis C?. (3rd June 2017) Authors: Chua, Joel V.; Kottilil, Shyam Journal: Expert review of gastroenterology & hepatology Issue: Volume 11:Number 6(2017) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Campylobacter fetus aortitis in a patient with HIV. (2021) Authors: Eke, Uzoamaka A.; Doub, James B.; Chua, Joel V. Journal: IDCases Issue: Volume 25(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2022) Authors: Welker, James; Pulido, Juan D; Catanzaro, Andrew T; Malvestutto, Carlos D; Li, Zihai; Cohen, Jonathan B; Whitman, Eric D; Byrne, Dana; Giddings, Olivia K; Lake, Jordan E; Chua, Joel V; Li, Ella; Chen, Jian; Zhou, Xiang; He, Kun; Gates, Davis; Kaur, Amarjot; Chen, Jamie; Chou, Hung-Yen; Devenport,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of COVID-19 on Pregnancy Outcomes: A Propensity Score Matched Study [A200]. (May 2022) Authors: Patel, Mayuri; Mangione, Mary; Perreand, Elsa; Miyamoto, Matthew; Cojocaru, Liviu; Chua, Joel V. Journal: Obstetrics and gynecology Issue: Volume 139(2022)Supplement 1 Page Start: 58S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial. Issue 29 (29th June 2021) Authors: Chua, Joel V.; Davis, Charles; Husson, Jennifer S.; Nelson, Amy; Prado, Ilia; Flinko, Robin; Lam, Ka Wing J.; Mutumbi, Lydiah; Mayer, Bryan T.; Dong, Dan; Fulp, William; Mahoney, Celia; Gerber, Monica; Gottardo, Raphael; Gilliam, Bruce L.; Greene, Kelli; Gao, Hongmei; Yates, Nicole; Ferrari, Guid... Journal: Vaccine Issue: Volume 39:Issue 29(2021) Page Start: 3879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study. Issue 6 (22nd November 2020) Authors: Chua, Joel V.; Ntem‐Mensah, Afua; Abutaleb, Ameer; Husson, Jennifer; Mutumbi, Lydiah; Lam, Ka Wing; Ghosh, Alip; Romani, Sara; Poonia, Bhawna; Lee, Sam; Luz Pascual, M.; Frumkin, Lyn R.; Kottilil, Shyamsundaran Journal: Journal of medical virology Issue: Volume 93:Issue 6(2021) Page Start: 3752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗